Neuropeptide Y (NPY) intranasal delivery alleviates Machado–Joseph disease

Abstract Machado–Joseph disease (MJD) is the most common dominantly-inherited ataxia worldwide with no effective treatment to prevent, stop or alleviate its progression. Neuropeptide Y (NPY) is a neuroprotective agent widely expressed in the mammalian brain. Our previous work showed that NPY overexp...

Descripción completa

Guardado en:
Detalles Bibliográficos
Autores principales: Joana Duarte-Neves, Cláudia Cavadas, Luís Pereira de Almeida
Formato: article
Lenguaje:EN
Publicado: Nature Portfolio 2021
Materias:
R
Q
Acceso en línea:https://doaj.org/article/5e8895de18654bcbb26bcfb30a822f35
Etiquetas: Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!